First published · Last updated
Safety Profile of Apalutamide in Prostate Cancer: A Pooled Analysis of Phase III Trials and the Under-Recognized Need for Real-World Thyroid Monitoring
A peer-reviewed article reports a pooled analysis of Phase III trials assessing apalutamide safety in prostate cancer and highlights a need for thyroid monitoring in real-world use. The supplied source fields include only the title, publisher, content type, and publication date.
Categories: public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 3/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 4/10
- Positivity
- 2/10
- Urgency
- 4/10
Why it matters
Identifies potential safety concerns that could affect monitoring practices for patients taking apalutamide.

